Proteomic analysis to identify markers for response to treatment in esophageal cancer.

被引：0
|
作者：
Zlotnik, Oran
Goshen-Lago, Tal
Brenner, Baruch
Kundel, Yulia
Menasherov, Nikolai
Kashtan, Hanoch
Ben-Aharon, Irit
机构：
[1] Rabin Med Ctr, Petah Tiqwa, Israel
[2] Davidoff Ctr Rabin Med Ctr, Petah Tiqwa, Israel
[3] Rabin Med Ctr Oncol, Davidoff Ctr, Hod Hasharon, Israel
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2019年 / 37卷 / 04期
关键词：
D O I：
10.1200/JCO.2019.37.4_suppl.61
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
61
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Analysis of costs of therapeutic alternatives for patients with esophageal cancer.
    Milano, MC
    Garcia, N
    Roca, E
    Ruiz, C
    Pennella, E
    GASTROENTEROLOGY, 1997, 112 (04) : A29 - A29
  • [22] Correlations of FDG-PET immunohistochemical markers and DNA analyses in esophageal cancer.
    Choi, JY
    Choi, Y
    Kim, JY
    Han, JH
    Choe, YS
    Lee, KH
    Kim, SE
    Shim, YM
    Kim, BT
    JOURNAL OF NUCLEAR MEDICINE, 1999, 40 (05) : 242P - 242P
  • [23] A proteomic analysis of surgical cytoreduction in patients with advanced ovarian cancer.
    Lesnock, Jamie L.
    Hood, Brian L.
    Sun, Mai
    Bhargava, Rohit
    Conrads, Thomas P.
    Krivak, Thomas C.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [24] Proteomic Analysis of Gallbladder Cancer to Identify Biomarkers and Therapeutic Targets
    Barbhuiya, Mustafa A.
    Subbannayya, Tejaswini
    Leal-Rojas, Pamela A.
    Shahasrabudhe, Nandini
    Renuse, Santosh
    Patil, Arun H.
    Garcia, Patricia
    Navani, Sanjay
    Tiwari, Pramod K.
    Santosh, Vani
    Prasad, T. S. Keshava
    Gowda, Harsha
    Yadav, Thakur D.
    Roa, Juan C.
    Chatterjee, Aditi
    Pandey, Akhilesh
    GASTROENTEROLOGY, 2015, 148 (04) : S571 - S571
  • [25] Proteomic analysis of papillary thyroid carcinoma to identify cancer biomarkers
    Sugimoto, Chizuru
    Narita, Norihiko
    Fujieda, Shigeharu
    CANCER SCIENCE, 2018, 109 : 215 - 215
  • [26] Proteomic approach to identify markers for invasive cervix cancer - A prospective pilot study.
    Mysona, David
    Pyrzak, Adam
    Allen, Jennifer
    Sharma, Ashok
    Zhi, Wenbo
    Rungruang, Bunja Jane
    Ghamande, Sharad A.
    She, Jin-Xiong
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [27] Expression of immune response markers in Arab patients with lung cancer.
    Jazieh, Abdul Rahman
    Bounedjar, Adda
    Bamefleh, Hanaa
    Al-Fayea, Turki
    Almaghraby, Hatim Q.
    Belarabi, Ayed
    Ouahioune, Wahiba
    Derbouz, Zoubir
    Alkaiyat, Mohammad
    Alkattan, Khaled
    Damlaj, Moussab
    Khalbuss, Walid
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [28] Chemoradiation as medical treatment for esophageal cancer. Is surgery always necessary?
    Bedenne, L.
    Hamza, S.
    Jouve, J. -L.
    ONCOLOGIE, 2013, 15 (3-4) : 139 - 143
  • [29] A retrospective analysis to identify variables predictive of achieving a pCR after neoadjuvant chemoradiation therapy for locally advanced esophageal cancer.
    Brooks, JA
    Werner, E
    Jain, NP
    Helft, PR
    Zon, RT
    Fineberg, NS
    Leblanc, J
    McHenry, L
    Einhorn, LH
    Kesler, KA
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 328S - 328S
  • [30] Impact of squamous histology on the response to treatment and long-term outcomes of patients with distal esophageal cancer.
    Shah, Parth Kishore
    Cameron, Miles
    Frakes, Jessica M.
    Fontaine, Jacques
    Coppola, Domenico
    Hoffe, Sarah E.
    Almhanna, Khaldoun
    Pimiento, Jose Mario
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
12345